Document Detail


Intensive immunosuppressive therapy improves pulmonary hemodynamics and long-term prognosis in patients with pulmonary arterial hypertension associated with connective tissue disease.
MedLine Citation:
PMID:  21873802     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Pulmonary arterial hypertension (PAH) remains a serious disease characterized by elevated pulmonary artery pressure (PAP) and increased pulmonary vascular resistance (PVR). Among its subtypes, PAH associated with connective tissue disease (CPAH) has the worse prognosis, because of resistance to conventional vasodilator therapy. We hypothesized that intensive immunosuppressive therapy (IIT) could improve the pulmonary hemodynamics in CPAH.
METHODS AND RESULTS: In our pulmonary hypertension (PH) cohort of 182 patients, we evaluated 13 consecutive patients with CPAH who received IIT combined with cyclophosphamide and glucocorticosteroids (IIT group, mean age 45 ± 8 years, 12 females and 1 male). We compared them with 8 historical controls (control group: mean age 52 ± 18 years, 8 females) for pulmonary hemodynamics and prognosis. Both groups were treated with conventional vasodilator therapy. Although the mean PAP (mPAP) remained unchanged in the control group, IIT significantly decreased mPAP (40 ± 9 to 29 ± 11 mmHg, P < 0.01) and tended to decrease PVR (700 ± 434 to 481 ± 418 dyne·s·cm⁻⁵, P=0.07). Importantly, in 6 of the 13 patients in the IIT group, mPAP was almost normalized (< 25 mmHg) and remained stabilized for more than 1 year. Furthermore, the IIT group showed significantly better prognosis compared with the control group (P<0.01). Conclusions: These results suggest that IIT as well as conventional vasodilator therapy improves the pulmonary hemodynamics and long-term prognosis of patients with CPAH.
Authors:
Saori Miyamichi-Yamamoto; Yoshihiro Fukumoto; Koichiro Sugimura; Tomonori Ishii; Kimio Satoh; Yutaka Miura; Shunsuke Tatebe; Kotaro Nochioka; Tatsuo Aoki; Zhulanqiqige Do E; Hiroaki Shimokawa
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-08-27
Journal Detail:
Title:  Circulation journal : official journal of the Japanese Circulation Society     Volume:  75     ISSN:  1347-4820     ISO Abbreviation:  Circ. J.     Publication Date:  2011  
Date Detail:
Created Date:  2011-10-26     Completed Date:  2012-02-14     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  101137683     Medline TA:  Circ J     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  2668-74     Citation Subset:  IM    
Affiliation:
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Cyclophosphamide / administration & dosage*
Female
Glucocorticoids / administration & dosage*
Humans
Hypertension, Pulmonary* / diagnosis,  drug therapy,  physiopathology
Immunosuppression*
Immunosuppressive Agents / administration & dosage*
Male
Middle Aged
Prognosis
Retrospective Studies
Vascular Resistance / drug effects*
Vasodilator Agents / administration & dosage*
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Immunosuppressive Agents; 0/Vasodilator Agents; 50-18-0/Cyclophosphamide
Comments/Corrections
Comment In:
Circ J. 2011;75(11):2543-4   [PMID:  21963571 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incremental Diagnostic Value of Regional Myocardial Blood Flow Quantification Over Relative Perfusio...
Next Document:  Low concordance between positive antibodies to thyroperoxidase and thyroid ultrasound autoimmune pat...